Drawing for JESFAMI

USPTO serial 79186799

JESFAMI

Reviewed by CopyMark Law Group

Reg. 5056977Status 404
Filing date
Status date
Registration date
Oct 11, 2016
Examiner
BELLO, ZACK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JESFAMI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

MAURY M. TEPPER, III TEPPER & EYSTER, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; biological preparations and stem cells for pharmaceutical and medical useSECTION 70 - CANCELLED—
044Collection and preservation of biological tissue, blood and cells; medical diagnostic services; medical treatment services; provision of information and data for diagnosis and medical treatmentSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 3, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Jan 3, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 10, 2020RFNTREFUSAL PROCESSED BY IB—
Jan 24, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jan 24, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 3, 2017FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 16, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 16, 2017FIMPFINAL DISPOSITION PROCESSED—
Jan 11, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 11, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 26, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 26, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 6, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 22, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 17, 2016RFNTREFUSAL PROCESSED BY IB—
Jun 15, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 14, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 14, 2016CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 11, 2016ALIEASSIGNED TO LIE—
Jun 6, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 6, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 2, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 2, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 27, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 27, 2016RFRRREFUSAL PROCESSED BY MPU—
May 27, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 26, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
May 20, 2016DOCKASSIGNED TO EXAMINER—
May 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2016LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 19, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance